WUXI BIO (02269) granted 288,400 restricted shares.
WuXi Biologics (02269) announced that on June 9, 2026, it has approved the issuance of a total of 288,400 restricted shares under a restricted share incentive plan, but it is subject to acceptance by the grantee before it can take effect.
WUXI BIO (02269) announced that on June 9, 2026, it has approved the issuance of a total of 288,400 restricted stock units under the Restricted Stock Unit Award Plan, but they will only become effective upon acceptance by the recipients designated under the plan.
Related Articles
DT CAPITAL (00356) plans to implement a "15 for 1" share consolidation and change the minimum trading unit.
YUNJI (02670) appoints Wang Kegui as a non-executive director.
SDITC(01697): Tian Zhiguo takes office as the General Manager of the company, as well as the Chief Compliance Officer.
DT CAPITAL (00356) plans to implement a "15 for 1" share consolidation and change the minimum trading unit.
YUNJI (02670) appoints Wang Kegui as a non-executive director.
SDITC(01697): Tian Zhiguo takes office as the General Manager of the company, as well as the Chief Compliance Officer.
